OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Monoclonal antibody therapies in the management of SARS-CoV-2 infection
Enrique Míguez‐Rey, Dasom Choi, Seungmin Kim, et al.
Expert Opinion on Investigational Drugs (2022) Vol. 31, Iss. 1, pp. 41-58
Open Access | Times Cited: 37
Enrique Míguez‐Rey, Dasom Choi, Seungmin Kim, et al.
Expert Opinion on Investigational Drugs (2022) Vol. 31, Iss. 1, pp. 41-58
Open Access | Times Cited: 37
Showing 26-50 of 37 citing articles:
A Conspectus Study in Treatment of COVID-19 using Monoclonal Antibodies
R. Kavitha, R. Lokesh, C Pooja
International Journal of Science and Research (IJSR) (2024) Vol. 13, Iss. 5, pp. 988-992
Open Access
R. Kavitha, R. Lokesh, C Pooja
International Journal of Science and Research (IJSR) (2024) Vol. 13, Iss. 5, pp. 988-992
Open Access
Study of Potential Blocking Peptides Targeting the SARS-CoV-2 RBD/hACE2 Interaction
Sara M. Villada-Troncoso, Jenny Andrea Arévalo-Romero, Vanessa Hernández Rivera, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 9, pp. 1240-1240
Open Access
Sara M. Villada-Troncoso, Jenny Andrea Arévalo-Romero, Vanessa Hernández Rivera, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 9, pp. 1240-1240
Open Access
Pharmacokinetics of the Monoclonal Antibody, Sotrovimab, in Healthy Participants Following IM Administration at Different Injection Sites
Asma El‐Zailik, Jennifer E. Sager, Yasmin Sánchez‐Pearson, et al.
Clinical Pharmacology & Therapeutics (2024)
Closed Access
Asma El‐Zailik, Jennifer E. Sager, Yasmin Sánchez‐Pearson, et al.
Clinical Pharmacology & Therapeutics (2024)
Closed Access
Vectored Immunoprophylaxis and Treatment of SARS-CoV-2 Infection
Takuya Tada, Belinda M. Dcosta, Julia Minnee, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Takuya Tada, Belinda M. Dcosta, Julia Minnee, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Development of a Series of Neutralizing Nanobodies against SARS-CoV-2 Spike Protein
Vladislav Zhuchkov, S. V. Ivanov, J. E. Kravchenko, et al.
Молекулярная биология (2023) Vol. 57, Iss. 3, pp. 505-516
Closed Access | Times Cited: 1
Vladislav Zhuchkov, S. V. Ivanov, J. E. Kravchenko, et al.
Молекулярная биология (2023) Vol. 57, Iss. 3, pp. 505-516
Closed Access | Times Cited: 1
Development of a Series of Neutralizing Nanobodies against SARS-CoV-2 Spike Protein
V. A. Zhuchkov, S. V. Ivanov, J. E. Kravchenko, et al.
Molecular Biology (2023) Vol. 57, Iss. 3, pp. 502-511
Closed Access | Times Cited: 1
V. A. Zhuchkov, S. V. Ivanov, J. E. Kravchenko, et al.
Molecular Biology (2023) Vol. 57, Iss. 3, pp. 502-511
Closed Access | Times Cited: 1
Describing COVID-19 Patients During The First Two Months of Paxlovid (Nirmatrelvir/Ritonavir) Initiation in a Large HMO in Israel
Lilac Tene, Gabriel Chodick, Noga Fallach, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
Lilac Tene, Gabriel Chodick, Noga Fallach, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
Tolerance and clinical outcomes of COVID ‐19 antiviral therapy in long‐term care residents
Shireesha Vuppalanchi, Lindsay Weaver, Kristina Box, et al.
Journal of the American Geriatrics Society (2022) Vol. 70, Iss. 10, pp. 3033-3035
Open Access | Times Cited: 2
Shireesha Vuppalanchi, Lindsay Weaver, Kristina Box, et al.
Journal of the American Geriatrics Society (2022) Vol. 70, Iss. 10, pp. 3033-3035
Open Access | Times Cited: 2
The use of neutralizing monoclonal antibodies against SARS-CoV-2 in hemodialysis patients
E.V. Volodina, N.F. Frolova, М. А. Лысенко, et al.
Infectious diseases News Opinions Training (2022) Vol. 11, Iss. 4, pp. 38-46
Open Access | Times Cited: 2
E.V. Volodina, N.F. Frolova, М. А. Лысенко, et al.
Infectious diseases News Opinions Training (2022) Vol. 11, Iss. 4, pp. 38-46
Open Access | Times Cited: 2
Population pharmacokinetics and exposure-response analysis of sotrovimab in the early treatment of COVID-19
Jennifer E. Sager, Asma El‐Zailik, Julie Passarell, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
Jennifer E. Sager, Asma El‐Zailik, Julie Passarell, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
Efficacy and safety of regdanvimab in patients with mild to moderate COVID‐19: A rapid review and meta‐analysis
Behnam Amani, Bahman Amani
British Journal of Clinical Pharmacology (2023) Vol. 89, Iss. 4, pp. 1282-1290
Open Access
Behnam Amani, Bahman Amani
British Journal of Clinical Pharmacology (2023) Vol. 89, Iss. 4, pp. 1282-1290
Open Access
Safety, Virology, Pharmacokinetics, and Clinical Experience of High-dose Intravenous Sotrovimab for the Treatment of Mild to Moderate COVID-19: An Open-label Clinical Trial
Jaynier Moya, Marisol Temech, Sergio Parra, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Jaynier Moya, Marisol Temech, Sergio Parra, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
